Consultant Proposes FDA/Industry Joint Panel In Place Of NDI Guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA should scrap its new dietary ingredient notification guidance in favor of an FDA/industry joint panel that would create safety proposals regarding new ingredients, a consultant says.